1-6 of 6
Francesca Bizzaro
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2816: Patient derived ovarian cancer xenograft (OC-PDX) to study the response of the PARP inhibitor olaparib

Francesca Bizzaro, Alessia C. Marchetti, Alessandra Decio, Francesca Ricci, Mark J. O'Connor, Molly A. Taylor, Zhongwu Lai, Simon T. Barry, Maria R. Bani, Raffaella Giavazzi
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2816.
https://doi.org/10.1158/1538-7445.AM2018-2816
Published: 01 July 2018
View article titled, Abstract 2816: Patient derived ovarian cancer xenograft (OC-PDX) to study the response of the PARP inhibitor olaparib
Journal Articles

Modeling Cytostatic and Cytotoxic Responses to New Treatment Regimens for Ovarian Cancer

Francesca Falcetta, Francesca Bizzaro, Elisa D'Agostini, Maria Rosa Bani, Raffaella Giavazzi, Paolo Ubezio
Journal: Cancer Research
Cancer Res (2017) 77 (23): 6759–6769.
https://doi.org/10.1158/0008-5472.CAN-17-1099
Published: 30 November 2017
View article titled, Modeling Cytostatic and Cytotoxic Responses to New Treatment Regimens for Ovarian Cancer
Open the PDF for Modeling Cytostatic and Cytotoxic Responses to New Treatment Regimens for Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 508: DNA repair status in a patient derived ovarian cancer xenobank

Federica Guffanti, Maddalena Fratelli, Monica Ganzinelli, Francesca Ricci, Roberta Affatato, Maria Rosa Cappelletti, Daniele Generali, Francesca Bizzaro, Massimo Broggini, Raffaella Giavazzi, Giovanna Damia
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 508.
https://doi.org/10.1158/1538-7445.AM2017-508
Published: 01 July 2017
View article titled, Abstract 508: DNA repair status in a patient derived ovarian cancer xenobank
Journal Articles

Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations

Francesca Ricci, Francesca Bizzaro, Marta Cesca, Federica Guffanti, Monica Ganzinelli, Alessandra Decio, Carmen Ghilardi, Patrizia Perego, Robert Fruscio, Alessandro Buda, Rodolfo Milani, Paola Ostano, Giovanna Chiorino, Maria Rosa Bani, Giovanna Damia, Raffaella Giavazzi
Journal: Cancer Research
Cancer Res (2014) 74 (23): 6980–6990.
https://doi.org/10.1158/0008-5472.CAN-14-0274
Published: 30 November 2014
View article titled, Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
Open the PDF for Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations in another window
Includes: Supplementary data
Journal Articles

Abstract 2994: Cediranib affects tumor progression and survival of mice bearing patient derived ovarian carcinoma xenografts (EOC-PDX)

Alessandra Decio, Marta Cesca, Francesca Bizzaro, Dorina Belotti, Raffaella Giavazzi
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2994.
https://doi.org/10.1158/1538-7445.AM2014-2994
Published: 01 October 2014
View article titled, Abstract 2994: Cediranib affects tumor progression and survival of mice bearing patient derived ovarian carcinoma xenografts (EOC-PDX)
Journal Articles

Abstract 5096: Heterogeneous response to antiangiogenic therapy in ovarian cancer xenografts: a tool to investigate biomarkers of resistance.

Alessandra Decio, Marta Cesca, Francesca Bizzaro, Valentina Scarlato, Carmen Ghilardi, Maria Rosa Bani, Raffaella Giavazzi
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 5096.
https://doi.org/10.1158/1538-7445.AM2013-5096
Published: 15 April 2013
View article titled, Abstract 5096: Heterogeneous response to antiangiogenic therapy in ovarian cancer xenografts: a tool to investigate biomarkers of resistance.